Professional Background
Director, Institute for Advancing Medical Innovation, University of Kansas Medical Center, Kansas City, KS 2009-Present
Associate Director – Translational Research, University of Kansas Cancer Center, Kansas City, KS 2012-Present
Program Co-Leader, Drug Discovery, Delivery and Experimental Therapeutics Research Program, University of Kansas CancerCenter, Kansas City, KS2006-2013; 2015-2017, 2019-2020
Acting Chief Scientific Officer, CicloMed LLC, Kansas City, MO2017-Present
Director, Office of Therapeutics, Discovery and Development, University of Kansas Cancer Center,Kansas City, KS 2006-2008
Senior Director, Preclinical Technologies, Aptuit LLC, Kansas City, MO 2005-2006
Vice President, Early Development and Laboratory Services, Quintiles Inc., Kansas City, MO 2000-2005
Executive Director, Biopharmaceutical Sciences, Quintiles, Inc., Kansas City, MO 1999-2000
Director, Drug Metabolism and Pharmacokinetics Department Hoechst, Marion, Roussel Inc., KansasCity, MO 1998-1999
Director, Pharmacokinetics Department, Hoechst, Marion, Roussel Inc., Kansas City, MO 1996-1998
Director and Acting Vice President, Pharmacokinetics Department, Hoechst, Marion, Roussel Inc.,Kansas City, MO 1995-1996
Director and Acting Vice President, Global Pharmacokinetics Department, Marion Merrell Dow Inc.,Kansas City, MO 1994-1995
Department Head, US Clinical Pharmacokinetics Department, Marion Merrell Dow Inc., Kansas City, MO 1992-1994
Team Leader, Clinical Pharmacodynamics Section, Clinical Pharmacology Department, MarionLaboratories Inc. and Marion Merrell Dow Inc., Kansas City, MO 1988-1992
Pharmacokineticist II, Clinical Pharmacokinetics Section, Clinical Pharmacology Department, MarionLaboratories, Inc., Kansas City, MO 1986-1988
- PharmD, Pharmacy, Univ. of Nebraska Medical Center, Omaha, Nebraska
- PhD, Pharmacokinetics and Biopharmaceutics, Univ. of Nebraska Medical Center, Omaha, Nebraska
- BSc, Biology, University of Nebraska at Omaha, Omaha, Nebraska
